Global Biologics Market Research Report: by Product (Monoclonal Antibody, Interleukins, Vaccines, Growth Factors, Gene Therapy, Others), by Disease Indication (Rheumatoid Arthritis, Psoriasis/Psoriatic Arthritis, Cancer, Diabetes, Others), by Manufac
SKU ID :MRF-13259728 | Published Date: 01-Feb-2019 | No. of pages: 138Description
TOC
Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of the Study
2.3 Assumptions & Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Healthcare Expenditure
4.2.2 Advancements in Biologics
4.2.3 Rising Prevalence of Chronic and Acute Diseases
4.3 Restraints
4.3.1 Emergence of Biosimilars
4.3.2 Adverse Effects of Biologic Drugs
4.4 Opportunities
4.4.1 Strong Pipeline for Biologic Drugs
5 Market Factor Analysis
5.1 Value/Supply Chain Analysis
5.1.1 Research & Development
5.1.2 Raw Material
5.1.3 Manufacturer
5.1.4 Distributor
5.1.5 Customer
5.1.6 Consumer
5.2 Porter’s Five Force Analysis
5.2.1 Threat from a New Entrant
5.2.2 Bargaining Power of Buyer
5.2.3 Bargaining Power of Supplier
5.2.4 Threat from Substitute
5.2.5 Rivalry
5.3 Investment Opportunity Analysis
5.3.1 Investment Risks
5.3.2 Market Outlook
5.4 Pricing Analysis
6 Global Biologics Market, by Product
6.1 Overview
6.2 Monoclonal Antibody
6.2.1 Humanized
6.2.2 Human
6.2.3 Chimeric
6.2.4 Murine
6.3 Interleukins
6.4 Vaccines
6.5 Growth Factors
6.6 Gene Therapy
7 Global Biologics Market, by Disease Indication
7.1 Overview
7.2 Cancer
7.3 Rheumatoid Arthritis
7.4 Psoriasis/ Psoriatic Arthritis
7.5 Diabetes
7.6 Ankylosing Spondylitis
7.7 Ulcerative Colitis
7.8 Crohn's Disease
7.9 Juvenile Idiopathic Arthropathy
7.1 Cardiovascular Diseases
8 Global Biologics Market, by Manufacturing
8.1 Overview
8.2 In-house
8.3 Outsourced
9 Global Biologics Market, by Region
9.1 Overview
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 UK
9.3.1.4 Italy
9.3.1.5 Spain
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive Landscape
10.1 Company Market Share Analysis
10.2 Competitive Scenario
11 Company Profiles
11.1 AbbVie, Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products/Services Offering
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 Pfizer Inc.
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products/Services Offering
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 AstraZeneca
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products/Services Offering
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 Novartis AG
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offering
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 F. Hoffmann-La Roche AG
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offering
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.5.6 Key Strategy
11.6 Bayer AG
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offering
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 Amgen
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offering
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Sanofi
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offering
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 Eli Lilly and Company
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offering
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 GlaxoSmithKline Plc (GSK)
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offering
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
12 Appendix
12.1 Discussion Blue Print
Tables & Figures
List of Tables:
TABLE 1 GLOBAL BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 2 GLOBAL BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 3 GLOBAL BIOLOGICS MARKET FOR INTERLEUKINS BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 4 GLOBAL BIOLOGICS MARKET FOR HUMAN BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 5 GLOBAL BIOLOGICS MARKET FOR CHIMERIC BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 6 GLOBAL BIOLOGICS MARKET FOR MURINE BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 7 GLOBAL BIOLOGICS MARKET FOR INTERLEUKINS BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 8 GLOBAL BIOLOGICS MARKET FOR VACCINES BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 9 GLOBAL BIOLOGICS MARKET FOR GROWTH FACTORS BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 10 GLOBAL BIOLOGICS MARKET FOR GENE THERAPY BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 11 GLOBAL BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 12 GLOBAL BIOLOGICS MARKET FOR CANCER BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 13 GLOBAL BIOLOGICS MARKET FOR RHEUMATOID ARTHRITIS BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 14 GLOBAL BIOLOGICS MARKET FOR PSORIASIS/ PSORIATIC ARTHRITIS BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 15 GLOBAL BIOLOGICS MARKET FOR DIABETES BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 16 GLOBAL BIOLOGICS MARKET FOR ANKYLOSING SPONDYLITIS BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 17 GLOBAL BIOLOGICS MARKET FOR ULCERATIVE COLITIS BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 18 GLOBAL BIOLOGICS MARKET FOR CROHN'S DISEASE BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 19 GLOBAL BIOLOGICS MARKET FOR JUVENILE IDIOPATHIC ARTHROPATHY BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 20 GLOBAL BIOLOGICS MARKET FOR CARDIOVASCULAR DISEASES BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 21 GLOBAL BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 22 GLOBAL BIOLOGICS MARKET FOR IN-HOUSE BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 23 GLOBAL BIOLOGICS MARKET FOR OUTSOURCED BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 24 GLOBAL BIOLOGICS MARKET BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 25 AMERICAS BIOLOGICS MARKET BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 26 AMERICAS BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 27 AMERICAS BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 28 AMERICAS BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 29 AMERICAS BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 30 NORTH AMERICA BIOLOGICS MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION)
TABLE 31 NORTH AMERICA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 32 NORTH AMERICA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 33 NORTH AMERICA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 34 NORTH AMERICA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 35 US BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 36 US BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 37 US BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 38 US BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 39 CANADA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 40 CANADA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 41 CANADA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 42 CANADA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 43 SOUTH AMERICA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 44 SOUTH AMERICA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 45 SOUTH AMERICA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 46 SOUTH AMERICA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 47 EUROPE BIOLOGICS MARKET BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 48 EUROPE BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 49 EUROPE BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 50 EUROPE BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 51 EUROPE BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 52 WESTERN EUROPE BIOLOGICS MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION)
TABLE 53 WESTERN EUROPE BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 54 WESTERN EUROPE BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 55 WESTERN EUROPE BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 56 WESTERN EUROPE BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 57 GERMANY BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 58 GERMANY BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 59 GERMANY BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 60 GERMANY BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 61 FRANCE BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 62 FRANCE BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 63 FRANCE BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 64 FRANCE BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 65 UK BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 66 UK BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 67 UK BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 68 UK BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 69 ITALY BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 70 ITALY BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 71 ITALY BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 72 ITALY BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 73 SPAIN BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 74 SPAIN BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 75 SPAIN BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 76 SPAIN BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 77 REST OF WESTERN EUROPE BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 78 REST OF WESTERN EUROPE BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 79 REST OF WESTERN EUROPE BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 80 REST OF WESTERN EUROPE BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 81 EASTERN EUROPE BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 82 EASTERN EUROPE BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 83 EASTERN EUROPE BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 84 EASTERN EUROPE BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 85 ASIA-PACIFIC BIOLOGICS MARKET BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 86 ASIA-PACIFIC BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 87 ASIA-PACIFIC BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 88 ASIA-PACIFIC BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 89 ASIA-PACIFIC BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 90 JAPAN BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 91 JAPAN BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 92 JAPAN BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 93 JAPAN BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 94 CHINA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 95 CHINA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 96 CHINA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 97 CHINA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 98 INDIA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 99 INDIA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 100 INDIA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 101 INDIA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 102 AUSTRALIA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 103 AUSTRALIA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 104 AUSTRALIA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 105 AUSTRALIA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 106 SOUTH KOREA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 107 SOUTH KOREA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 108 SOUTH KOREA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 109 SOUTH KOREA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 110 REST OF ASIA-PACIFIC BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 111 REST OF ASIA-PACIFIC BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 112 REST OF ASIA-PACIFIC BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 114 MIDDLE EAST & AFRICA BIOLOGICS MARKET BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 115 MIDDLE EAST & AFRICA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 119 MIDDLE EAST BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 120 MIDDLE EAST BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 121 MIDDLE EAST BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 122 MIDDLE EAST BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)
TABLE 123 AFRICA BIOLOGICS MARKET BY PRODUCT, 2015 TO 2023 (USD MILLION)
TABLE 124 AFRICA BIOLOGICS MARKET FOR MONOCLONAL ANTIBODY BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 125 AFRICA BIOLOGICS MARKET BY DISEASE INDICATION, 2015 TO 2023 (USD MILLION)
TABLE 126 AFRICA BIOLOGICS MARKET BY MANUFACTURING, 2015 TO 2023 (USD MILLION)List of Figures:
FIGURE 1 MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS
FIGURE 3 TOP DOWN & BOTTOM-UP APPROACH
FIGURE 4 MARKET DYNAMICS: GLOBAL BIOLOGICS MARKET
FIGURE 5 VALUE CHAIN: GLOBAL BIOLOGICS MARKET
FIGURE 7 GLOBAL BIOLOGICS MARKET BY PRODUCT, 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL BIOLOGICS MARKET BY DISEASE INDICATION, 2017 & 2023 (USD MILLION)
FIGURE 9 GLOBAL BIOLOGICS MARKET BY MANUFACTURING, 2017 & 2023 (USD MILLION)
FIGURE 10 GLOBAL BIOLOGICS MARKET BY REGION, 2017 & 2023 (USD MILLION)
FIGURE 11 AMERICAS BIOLOGICS MARKET BY REGION, 2017 (%)
FIGURE 12 NORTH AMERICA BIOLOGICS MARKET SHARE BY COUNTRY, 2017 (%)
FIGURE 13 EUROPE BIOLOGICS MARKET BY REGION, 2017 (%)
FIGURE 14 WESTERN EUROPE BIOLOGICS MARKET BY COUNTRY, 2017 (%)
FIGURE 15 ASIA-PACIFIC BIOLOGICS MARKET BY REGION, 2017 (%)
FIGURE 16 MIDDLE EAST & AFRICA BIOLOGICS MARKET BY REGION, 2017 (%)
FIGURE 17 GLOBAL BIOLOGICS MARKET, MARKET SHARE ANALYSIS 2017 (%)
FIGURE 18 GLOBAL BIOLOGICS MARKET COMPETITIVE LANDSCAPE (%)
Companies
Novartis AG (Switzerland), F. Hoffman-La Roche AG (Switzerland), AbbVie, Inc. (U.S.), Pfizer Inc. (U.S.), AstraZeneca (U.K.), Bayer AG (Germany), Amgen (U.S.), GlaxoSmithKline Plc (U.K.), Sanofi (France), Eli Lilly and Company (U.S.)
- PRICE
-
$4450$6250